Sir,
Cryptosporidium was reported by Tyzzer in 1907 and well known to veterinarians since 1953. Since the human immunodeficiency virus (HIV) and acquired immune deficiency syndrome became pandemic, it has brought Cryptosporidium to the forefront as an important pathogen in immunocompromised individuals. Cryptosporidium hominis and Cryptosporidium parvum are the two major species causing human cryptosporidiosis in India, followed by Cryptosporidium felis and Cryptosporidium meleagridis. Here, we describe the first report of Cryptosporidium viatorum in a patient attending our tertiary care center. C. viatorum has been reported in the UK in travelers returning from the Indian subcontinent. [1] Stool sample from a 35-year-old HIV-seropositive female presenting with diarrhea showed the presence of Cryptosporidium oocysts using microscopy. The small subunit rRNA (ssu rRNA) sequence showed 100% identity with three isolates of C. viatorum (JX978271, JN846708, HM485434) present in the GenBank. The sequence was submitted to GenBank under the accession no. KX174309. C. viatorum n. sp. was first identified in travelers with gastrointestinal symptoms returning to Great Britain from the Indian subcontinent. [1] However, no reports of C. viatorum are available so far from India. C. viatorum was identified in HIV-seropositive patients in Nigeria and Ethiopia and in Swedish patients who had traveled to Kenya and Guatemala. [2] [3] [4] [5] The patient belonged to rural area in Uttar Pradesh, a state in the northern part of India, had a history of contact with cattle. The potential for zoonotic transmission between cattle and humans in India has previously been reported. [1] Likewise, patients infected with C. viatorum in Kenya and Ethiopia had a history of animal contact. So far, no animal reservoir for C. viatorum has been described, but the possibility to identify this species in animal hosts cannot be excluded.
[4] The patient had acute diarrhea without any history of vomiting. Elwin et al. reported that 90% of C. viatorum cases had diarrhea, 50% had abdominal pain and fever, 20% had nausea, and only 10% had vomiting. However, compared to C. parvum, vomiting was reported less often. No association of C. viatorum with vomiting was seen in HIV-seropositive patients from Ethiopia.
The report warrants the need of further studies in humans and animals from the Indian subcontinent based on ssu rRNA sequencing for the specific detection of C. viatorum. It is expected that accumulating data will add to our understanding of the phylogeography, host specificity, and clinical significance of this little-studied parasite.
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Loeffler's Syndrome Secondary to Hyperinfection by Strongyloides stercoralis Associated with Methotrexate in a Patient with Rheumatoid Arthritis
Sir, Strongyloidiasis is endemic in tropical and subtropical regions. The overall prevalence may exceed 25%, especially in the southeastern areas of the United States and in people who have recently traveled to endemic areas. [1, 2] It is estimated to affect at least 60 million people. [3] Herein, we present the first case of Loeffler's syndrome secondary to Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis on methotrexate therapy who was successfully treated with ivermectin.
A 74-year-old Hispanic female with a history of breast cancer in clinical remission for 10 years, rheumatoid arthritis on weekly methotrexate presented to the emergency department with complaints of a 1 week history of dark bloody and mucoid diarrhea, with frequency of 8-9 times of bowel movements daily associated with nausea and nonbloody nonbilious vomiting. She also complained of poorly localized upper colicky abdominal pain. She traveled to Puerto Rico 2 months ago. On physical examination, she had a bilateral tender erythematous rash on the shin surfaces of her legs and sides of the ankles. Laboratory testing was significant for white blood cell count (WBC) of 16,000 with eosinophils of 27%. On day 3, the WBC subsequently increased to 26,000 of which 60% wereeosinophils and the absolute eosinophilic count was 15,800. The patient started to experience cough, wheezing, and shortness of breath. Arterial blood gases revealed severe hypoxia. Chest X-ray showed bilateral increased interstitial infiltrates in the lung fields. Doppler ultrasound of the lower extremities showed a common femoral vein deep vein thrombosis and was managed with inferior vena caval filter due to the fact that the patient had continuous bloody bowel movements. On day 4, stool analysis revealed microscopic evidence of S. stercoralis larvae. She was started on ivermectin 15 mg daily for 2 days, the WBC trended down from 26 to 16.3 over 48 h, and absolute eosinophils trended down from 15.6 to 5.2, diarrhea stopped, and the rash resolved completely over 4 days with complete resolution of the erythema that started to develop into a desquamative pattern. Her respiratory status also improved dramatically. Human T-cell leukemia virus type 1 and 2 antibodies were negative. The patient clinically improved and was subsequently discharged from the hospital. S. stercoralis was not detected in the subsequent follow-up stool examinations thereafter.
S. stercoralis is a parasitic nematode that affects gastrointestinal, cutaneous, pulmonary systems. The infection occurs after the parasite (filariform larvae form), which is usually found in the soil and human feces, penetrates the human skin, and from there, the parasite migrates to the lungs hematogenously. [4, 5] The larvae migrates from the lung alveolar sacs to the tracheobronchial tree and subsequently will be ingested to the gastrointestinal tract. In the gastrointestinal tract, it transforms into the adult worms which will reside in the duodenojejunal mucosa and produce eggs that transform into the rhabditiform (noninfectious form) which are passed with feces and mature into filariform larvae. These larvae then penetrate the intestinal mucosa and the perianal skin. In the case we presented, the patient had Loeffler's syndrome which manifested as pulmonary symptoms of wheezing in the setting of hypereosinophilia and diarrhea. The pulmonary symptoms were severe enough to cause hypoxia. The pulmonary symptoms, the radiographic findings, and the hypereosinophilia supported the diagnosis of Loeffler's syndrome which is a very rare manifestation of Strongyloides infection.
[5] This, to our knowledge, is the first reported case of Loeffler's syndrome secondary to methotrexate-related hyperinfection syndrome related to S. stercoralis that clinically responded to ivermectin therapy. Methotrexate
